Christopher Posner
CIK 1748265 · PRESIDENT AND CEO · last filed 2025-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
23
Lifetime Open-Market Net
-$427.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (CARA) Delisted | PRESIDENT AND CEO | 13,109 | $15.96 | $209.2K | -$427.4K | 23 | 2025-03-04 |
Recent Filings · Page 2 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-09 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −3,869 | -$17.0K | EDGAR |
| 2023-03-07 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −5,987 | -$58.1K | EDGAR |
| 2023-03-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −4,191 | -$49.5K | EDGAR |
| 2022-11-18 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −14,470 | -$161.1K | EDGAR |
| 2022-04-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,006 | -$25.4K | EDGAR |
| 2022-03-01 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +39,000 | $0 | EDGAR |
| 2021-11-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +147,941 | $0 | EDGAR |
| 2021-06-07 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +4,896 | -$30.0K | EDGAR |
| 2020-11-23 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,000 | -$31.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.